Probiotic capsule trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN53164826

Enrollment

Registered

2005-05-24

Start date

2004-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects Nutritional, Metabolic, Endocrine

Interventions

Probiotic capsule versus placebo capsule. 1. The study group members (8 males and 4 females) took three probiotic containing capsules (8.4 log colony forming unit [CFU] per capsule) two times daily (d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria included the wish to participate, no known health problems, no medical conditions requiring drug therapy, no other yoghurts or no special diets.

Exclusion criteria

Exclusion criteria: Subjects with a history of gastrointestinal tract (GIT) disease, food allergy and acute infection, use of any antimicrobial agent within the last month or use of any regular concomitant medication were excluded.

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

Estonia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026